Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
life sciences
national blog main
biology
biotech
boston blog main
boston top stories
medical devices
medicine
startups
alphabet
ankit agarwal
antibiotic resistance
argentum medical
bio
boston
broad institute of harvard and mit
brook byers
cancer
cdc
charles chu
clinical trials
codiak biosciences
coloplast
coronavirus
covid-19
crispr cas14
cutaneous t-cell lymphoma
deals
decheng capital
diagnostic
exosome
extreme
formidable asset management
genetics
google
health
healthtech
hhs
imbed biosciences
What
based
5
×
biosciences
5
×
crispr
begin
cas
faster
tiny
using
access
acts
allowing
antibiotic
antibiotics
approval
approves
available
big
bio
bio’s
boost
brings
bubbles
called
carolina
cells
centers
certain
cheaper
class
clinical
codiak
company
coronavirus
covid
crisis
crispr’s
cure
develop
developer
diagnostics
Language
unset
Current search:
biosciences
×
based
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@extremetech.com
4 years ago
FDA Approves CRISPR-Based Coronavirus Test
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings
@techcrunch.com
7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis